It has been postulated that agalactosyl immunoglobulin G (IgG) self-associates to form pathological aggregates in the rheumatoid joint. To examine this hypothesis, IgG aggregates from synovial fluid (SF) of 22 patients with RA were prepared by precipitation with polyethylene glycol (PEG) 6000. The PEG precipitates and SFs were reduced with 2-mercaptoethanol (2ME) and bound to protein G. This procedure isolated the IgG in the PEG precipitates from other contaminating glycosylated proteins. The levels of galactose and A^-acetylglucosamine (GlcNAc) residues present on the reduced IgG were quantified by their ability to bind the lee tins Ricinus communis (RCA)i» and Bandeiraea simplicifolia (BS) II. Proportionally less galactose (expressed as a ratio of bound RCAis to BS IT) was present on the IgG from the PEG precipitates than on the IgG in the paired SF (P = 0.001). However, in many cases more RCA,» as well as BS II bound to IgG from PEG precipitates than from the corresponding SF. It is considered that agalactosyl IgG occurs preferentially in RA SF PEG precipitates and that this IgG may also exhibit increased Fab glycosylation.
JOINT pain and swelling are prominent features of RA, and cause the patient enormous pain and discomfort. The precise pathways leading to these signs and symptoms of RA remain uncertain. It is known, however, that IgG aggregates in synovial fluid (SF) activate complement which contributes to the accumulation of polymorphonuclear leucocytes (PMNs) in the joint space [1, 2] . IgG aggregates in the SF trigger the degranulation response of PMNs from RA synovial fluid, releasing granule enzymes including myeloperoxidase [3] and kininogenases [4] . Many of the effects of activated complement components and kinins (including vasodilation, increased vascular permeability, leucotaxis and pain) form the cardinal signs and symptoms of acute inflammation. The local production of these agents, together with prostaglandins produced by the synovium [5] , may largely be responsible for the joint tenderness and pain found in RA patients. The mechanism for IgG aggregation is still debated. The phlogistic aggregates, which bear C3d, do not contain rheumatoid factor or other antigen-antibody complexes [2, 6] . They may be formed from self-associating IgG [7] .
IgG is a glycoprotein with a conserved N-linked glycosylation site in both C H 2 domains. The oligosaccharides found here are of the complex type and over 30 different glycoforms of IgG may normally be present in the serum [8] . X-ray crystallographic data of IgG show a well-defined binding site for terminal galactose of such oligosaccharides in the C H 2 domain [9] . The idea that the glycosylation of IgG may alter in RA and be part of the disease pathology stems from the work of Mullinax et al. [10] who reported an apparent decrease in the galactose content of the Fc region of RA serum IgG. Later, they described a decrease in the galactose content of the Fc region of aggregated IgG derived from the serum of an RA patient, but an increase in the F(ab) 2 region [11] . It is now known that the change in the Fc region is due to lack of terminal galactose residues from the biantennary oligosaccharides at the Fc conserved glycosylation site [8] . Moreover, the percentage of agalactosyl IgG is higher in some SFs than the corresponding sera, suggesting that agalactosyl IgG may be produced in the joint in RA patients [12] . It has been suggested [7, 8] that IgG in the aggregates found in rheumatoid serum and SF may be formed by F(ab) 2 oligosaccharides inserting into the vacant 'pocket' in the Fc of IgG lacking galactose. If this were true, it would be hypothesized that IgG from SF aggregates would contain greater amounts of agalactosyl IgG than non-aggregated IgG from the same SF, and that the same IgG may also bear more oligosaccharides in the Fab. To test this hypothesis, IgG from aggregates in the SF of RA patients was isolated, and its ability to bind lectins that detect terminal galactose and 7V-acetylglucosamine (GlcNAc) residues compared with that of unaggregated IgG obtained from the same SF.
MATERIALS AND METHODS

Synovial fluids
Synovial fluids were collected from 22 patients who fulfilled standard criteria for classical RA, attending the rheumatology department at British Royal Infirmary, Bristol. Fluid was removed for therapeutic purposes only, and was collected into citrate.
Precipitation of immune complexes
Immune complexes were precipitated from SFs with polyethylene glycol (PEG) 6000 in the following manner. Two hundred microlitres of 15% PEG 6000 in veronal buffered saline (VBS) supplemented with 0.06 M disodium ethylenediaminetetraacetic acid (EDTA) were added to 1 ml of synovial fluid. After overnight incubation at 4°C, the fluids were centrifuged at 2000 g for 20 min, the pellets resuspended in 1 ml of ice-cold 2.5% PEG 6000 in VBS supplemented with 0.01 M EDTA and centrifuged as before. The supernatant was removed to leave the pellets dry and they were made up to the original volume (1 ml) with VBS. The pellets were incubated at 37°C in VBS for 2 h, then thoroughly resuspended.
Isolation of IgG-containing PEG-precipitated aggregates
PEG precipitates were diluted 1 + 1 in 0.1 M sodium acetate (pH 5.0) and passed down a 0.5 ml column of Protein G immobilized on agarose (Pierce) that had been pre-equilibrated with 5 column vols of sodium acetate. The column was then washed with a further 15 column vols of sodium acetate to elute all unbound proteins. The bound, IgG-containing complexes were eluted by passing 1 column vol of 0.1 M glycine/HCl (pH 2.5) through the column, discarding this fraction and then collecting the IgG complexes in a further 3 column vols of 0.1 M glycine/HCl (pH 2.5). The eluted fraction was concentrated 5-fold using an Amicon minicon concentrator.
Reduction and alkylation
Synovial fluids and PEG precipitates were reduced by incubation with 2-mercaptoethanol (2ME). Synovial fluids were diluted 1/50 in 0.12 M 2ME in 0.1 M Tris (pH 8.0). Six microlitres of 2 M 2ME (in 0.1 M Tris, pH 8.0) were added to 100 /il of the PEG precipitates to give a final concentration of 0.12 M 2ME. After incubation for 1 h at 37°C, the samples were cooled on ice for 15 min, then 1 M iodoacetamide was added to give a final iodoacetamide concentration of 0.11 M and the samples incubated for a further 1 h on ice.
Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE)
The molecular weights of components in PEG precipitates, IgG-containing PEG precipitates purified on protein G and IgG purified on Protein G were determined by SDS-PAGE [13] . The gels were stained with a silver stain [14] .
Western blotting
SDS-PAGE was performed as above, and the gels were then blotted onto nitrocellulose using the technique of Burnette [15] . The nitrocellulose was blocked overnight at 4°C in 5% bovine serum albumin (BSA) in phosphate-buffered saline (PBS). The IgG present was then stained for 1 h at 37°C with a peroxidase-labelled anti-human IgG (whole molecule), diluted 1/1000 in 5% BSA in PBS. The nitrocellulose was washed six times with 0.1% Tween 20 in PBS and the IgG bands were then visualized luminographically [16] . Alternatively, blots were also probed with biotinylated Ricinus communis (RCA)| M and Bandeiraea simplicifolia (BS) II, essentially as described by Sumar et al. [17] . After staining with streptavidin peroxidase, the bands were visualized luminographically [15] .
Quantitation of IgG
The IgG concentration was quantified by a sandwich ELISA [18] , using goat anti-human IgG as capture antibody and peroxidase-labelled goat anti-human IgG (Fc-specific) as a detection antibody, and using 1 mg of tetramethyl benzidine (TMB) with 3/il of H2O2 in 10 ml of citrate buffer (pH 5.0) as substrate. The reaction was stopped with 2 M H 2 SO 4 and the colour intensity measured at 450 nm. Samples were reduced and alkylated as described above prior to quantitation.
Determination of IgG galactosylation
Ninety-six well flat-bottomed plates (Nunc, Immunoplate I) were coated overnight at 4°C with recombinant Protein G (Sigma, UK) at 5 /ig/ml in PBS (pH 7.3). After blocking for 1 h at 37°C with 0.5% BSA and 0.1% Tween 20 in PBS (PBS/BSA/Tw), the plates were washed three times in 0.1% Tween 20 in PBS (PBS/Tw) and 50 /il of the reduced samples applied in triplicate to one plate at 2.5 /ig IgG/ml and another at 10 /ig IgG/ml in 0.1 M sodium acetate (pH 5.0). After a further incubation at 37°C for 2 h, the plates were washed three times in PBS/Tw and the biotinylated lectins RCA 120 (Sigma, UK) and BS II (Vector Laboratories), which recognize terminal /?-r>galactose and D-A r -acetylglucosamine, respectively, were applied. RCA 120 was diluted to 0.06 /ig/ml and BS II to 10 /ig/ml in PBS/BSA/Tw, then 50 /il of each were applied to each well of the plates that had IgG at 2.5 and 10 /ig/ml, respectively. After a further incubation for 2 h at 37°C, the plates were washed three times and 50 /il ExtrAvidin-Peroxidase at 10 /ig/ml in PBS/BSA/ Tw were added to each well. The plates were incubated at 37°C for 1 h before developing with TMB in citrate buffer as described for the quantitation of IgG. The results were expressed as a ratio of the OD 4 JO for RCAi» binding :BS II binding, and a standard curve constructed from standards of known percentage agalactosyl IgG (kindly quantified by Prof. G. Rook and Prof. F. Hay), enabling the percentage agalactosyl IgG to be estimated in the test samples.
RESULTS
Analysis of PEG precipitates from RA synovial fluid
The first step towards measuring the galactosylation of IgG in the PEG precipitates was to determine whether other proteins, which may also be glycosylated, were included in the precipitates or the IgG-containing aggregates within those precipitates. Upon analysis of the precipitates, many bands as well as the heavy and light chains of IgG were evident by silver stain (Fig. la, track 1 ). PEG precipitates that had been bound to and then eluted from a Protein G column (and hence should include only those aggregates that contain IgG) were found to contain far fewer bands than the unfractionated precipitates. However, 12 bands other than those of IgG heavy and light chains were still detected (Fig. la, track 2 RCA120 binding (Fig. 2, track 1) , and two bands also bound BS II (Fig. 2, track 2) . By contrast, IgG-containing aggregates purified by Protein G chromatography contained only one band (other than IgG heavy and light chain) that stained weakly with RCAuo and none that stained with BS II (Fig. 2 , tracks 3 and 4, respectively).
Dissociation of IgG-containing complexes
As many glycoproteins that bound RCA 1J0 and BS II were found in PEG precipitates, it was necessary to disrupt the precipitates and isolate the IgG. Reduction of the proteins associated with the aggregated IgG may dissociate them from IgG. To test this idea, PEG precipitates were reduced and alkylated and subjected to Protein G chromatography, since reduced IgG is known to bind to Protein G [12] . The bound fraction was examined by SDS-PAGE and Western blotting. In addition to the IgG heavy chain band, identified by Western blotting, only five weakly staining bands were detected by silver stain in the bound fraction (Fig. lb) and only the band at 55 kDa, corresponding to the IgG heavy chain, bound either RCAi» or BS II (Fig. 2 , tracks 5 and 6). Note the reduction in the number of bands as compared with that seen in the Protein G-bound fraction from the original unreduced PEG precipitate (Fig. la, track 2) . A contaminating band at 65 kDa (presumed to be BSA) was present in all the fractions examined.
IgG concentration in synovial fluid and PEG precipitates
It was necessary to quantify the IgG present in the precipitates and the SF, as the assay to determine the IgG galactosylation required the samples and standards to be applied at the same concentration. Many anti-IgG sera are capable of binding to IgG in its reduced form, and it was found that the polyclonal anti-IgG heavy chain used here would still bind reduced IgG from a standard IgG preparation (data not shown). The IgG concentration in the reduced PEG precipitates was found to be a variable proportion of the IgG found in the paired reduced SF, varying from < 1 to 4% of the IgG in the SF. (Table I) . A wide range of SF IgG concentrations were also observed in the 22 samples tested.
Standardization of lectin binding assay
Having determined the IgG concentrations in the SFs and PEG precipitates, the galactosylation of the IgG could now be determined. The binding of the lectins RCAuo (detects galactose) and BS II (detects GlcNAc) to the standards was inversely related (Fig. 3a  and b) . The standard with a low percentage agalactosyl IgG bound more RCAi» and less BS II than those that were more agalactosyl. By comparison, the standard that was 100% agalactosyl bound little RCAuo but much BS II. A standard curve was obtained by expressing the results as a ratio of the RCA m to BS II binding, and a typical result is shown in Fig. 4 . Standards were applied to every plate. The reproducibility of the assay was tested, and the coefficient of variance for both inter-and intraplate variability was 8%. 
Percentage agalactosyl IgG in synovial fluids and PEG precipitates
A comparison was made between the percentage agalactosyl IgG in RA SFs and paired PEG precipitates derived therefrom. The results revealed a significant increase in the percentage of IgG that was agalactosyl in the PEG precipitates compared to the SFs (difference between the mean of the two groups, Student's Mest P = 0.001) (Fig. 5) . Where the percentage agalactosyl IgG was <55% in the synovial fluid, the increase in the PEG precipitates was greater and more significant (P < 0.001). In those samples in which the synovia] fluid had >55% agalactosyl IgG, the increase was not apparent in the PEG precipitates (P > 0.01), and in one case was considerably decreased.
Increased glycosylation of IgG in PEG precipitates
It was observed in many cases that although the PEG precipitates were proportionally less galactosylated than the paired SF, they bound more RCAi» as well as more BS II. The results for 10 SFs are recorded in Table II . Elevated RCA 120 binding was noted in 6/10 samples, despite increased BS II binding in all six of these samples (Table II) . DISCUSSION IgG in aggregates from SFs of RA patients was separated from monomeric IgG by precipitation with 2.5% PEG. Not surprisingly, as PEG is known to precipitate high-molecular-weight molecules or aggregates of lower-molecular-weight material, many proteins other than IgG were present in the precipitates. Some of these proteins were glycosylated, as judged by their ability to bind RCA^o and BS II. Thus, the IgG had to be isolated before the terminal glycosyl residues could be quantified by ELISA. Initially, PEG precipitates were subjected to Protein G chromatography. However, the isolated IgGcontaining aggregates still contained proteins other than IgG, although fewer were present than in the unfractionated precipitate. These remaining contaminating proteins may have been intimately associated with the IgG, as bound complement components, rheumatoid factor or antigen would be, or may have been non-specifically entrapped in the aggregates. Thus, the precipitates would have to be disrupted somehow to enable the isolation of IgG. To achieve this aim, PEG precipitates were reduced and alkylated before isolation of IgG on protein G. The results showed that material treated in such a way contained few contaminating proteins, and that only the IgG heavy chain bound RCAIM or BS II. An additional advantage which may accrue from the disruption of the C H 2 domain of IgG is that the lectins may have greater access to the carbohydrate contained therein.
The lectins RCAuo and BS II were used to detect galactose and GlcNAc residues, respectively, on the isolated IgG. Others have verified the specificity of these lectins for binding to galactose and GlcNAc residues, respectively, on IgG by inhibition experiments with the corresponding free sugars [16, 19] . All samples were assayed using both lectins and the results expressed as a ratio, thus permitting the proportional amount of a particular residue to be determined. This way of expressing the results corrects for any variation in the amount of IgG captured or any increase in the number of oligosaccharide moieties. It has been shown that methods that measure only one sugar residue (galactose, GlcNAc or sialic acid) may not correlate with methods that measure two or more [20] .
The main finding reported is that IgG heavy chains in aggregates from the rheumatoid joint were proportionally less galactosylated than the IgG in the original SF. It may be asked whether this finding results from the PEG precipitation procedure. This possibility is rendered unlikely by the recent finding that PEG precipitates from RA sera have a far higher proportion of agalactosyl IgG than similar precipitates from patients with Crohn's disease, systemic lupus erythematosus, infectious myocarditis or normal individuals' despite the fact that a high proportion of serum IgG|from patients with Crohn's disease, like that from RA patients, is agalactosyl [21] . Rather, these results suggest that the composition of the IgG aggregates from RA patients is distinct in carbohydrate content from those from other disease groups.
RA IgG has increased agalactosylation of the Fc oligosaccharides [8] . It is thus likely that the increased agalactosylation of the IgG in RA SF PEG precipitates as compared with the monomeric IgG in the fluid resides in the Fc region. Additionally, however, there was in many cases a concomitant increase in the RCAi M and BS II binding, demonstrating that the IgG from the aggregates was more heavily galactosylated as well as bearing more GlcNAc residues. This finding is similar to that of Bond et al. [19] who demonstrated that the IgG in immune complexes isolated by PEG precipitation from the serum of MRL-lpr/lpr mice (a murine model of autoimmune disease) had elevated levels of both galactose and GlcNAc. These results could be explained by the presence of more than one glycosylation site within the molecule. It is known that wherever the amino acid sequence Asn-X-Ser or Asn-X-Thr is generated in the variable region, an N-linked oligosaccharide may be attached at a non-conserved glycosylation site [22, 23] and inspection of human germline VH gene sequences revealed that some encode «uch glycosylation sequons [24] . It has also been demonstrated [11] that F(ab)2 sugars are important for the formation of IgG-IgG complexes. Results from the current study suggest that light chains may not contribute to the increased RCAia binding because the light chains failed to bind RCAuo or BS II after separation by SDS-PAGE, and that therefore the increased galactose content resides in the Fc region.
It could be argued that IgG from the aggregates should be completely agalactosyl if the absence of Fc galactose was mandatory for aggregation. However, galactosylated IgG may become attached to the aggregates in a number of ways. For example, IgG rheumatoid factor may bind to the aggregates and IgG may-reactwith unidentified antigens in the aggregates, althoughtBese-are not present in the complementactivating aggregates~~t2H»J--IgG may also become non-specifically entrapped inthe complex. More importantly, account needs to be taken of the observed increase in glycosylation of IgG from the aggregates. As already argued, this increase is most likely due to Fab glycosylation. If so, such IgG may be agalactosyl in the Fc, but galactosylated in the Fab. The problem of whether or not IgG aggregates in RA SF are formed by Fab oligosaccharides inserting into the vacant pocket in the Fc region of IgG lacking galactose can only be resolved by detailed structural analysis. Nevertheless, these results show that the IgG in RA SF aggregates is preferentially agalactosyl.
